Pivotal study of KX-01 in patients with actinic keratosis

Trial Profile

Pivotal study of KX-01 in patients with actinic keratosis

Planning
Phase of Trial: Phase III

Latest Information Update: 14 Aug 2017

At a glance

  • Drugs KX 01 (Primary)
  • Indications Actinic keratosis
  • Focus Registrational; Therapeutic Use
  • Sponsors Athenex
  • Most Recent Events

    • 14 Aug 2017 Planned initiation date changed from 1 Oct 2016 to 1 Jul 2017, according to an Athenex media release.
    • 17 Dec 2015 New trial record
    • 15 Dec 2015 According to Athenex media release, company is planning to initiate this trial in the fourth quarter of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top